Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,489 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07374731 | Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer(DSCb score) | recruiting | — | 192 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT04669171 | A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma(SIDNEY) | recruiting | Phase 1 / Phase 2 | 80 | EnteromeINDUSTRY |
| 4 |
| Jan 30, 2026 |
| clinicaltrials |
| NCT06097156 | Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications | recruiting | — | 45 | Tethis S.p.A.INDUSTRY | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06840119 | Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers | recruiting | Phase 1 / Phase 2 | 600 | Immunocore LtdINDUSTRY | 6 | Jan 28, 2026 | clinicaltrials |
| NCT07372690 | Goal Attainment Scale in Transplantation(GAST) | recruiting | N/A | 176 | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'AnnaOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07373626 | Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic(MOREACTIVE2025) | recruiting | — | 50 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT04373564 | Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years(ODYSSEY) | recruiting | Phase 4 | 2,076 | GuerbetINDUSTRY | 8 | Jan 22, 2026 | clinicaltrials |
| NCT07299357 | Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial | recruiting | — | 53 | Istituto Clinico HumanitasOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07317245 | HUmanitas PROtontherapy (HU-PRO)(HU-PRO) | recruiting | — | 500 | Istituto Clinico HumanitasOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07354165 | Financial Toxicity in Patients With Early-stage Breast Cancer(VOICE - GIM36) | recruiting | — | 864 | National Cancer Institute, NaplesOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07357259 | Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.(SPIR202302) | recruiting | N/A | 244 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07352514 | Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial | recruiting | — | 40 | University of PalermoOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06712459 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | recruiting | — | 100 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 7 | Jan 16, 2026 | clinicaltrials |
| NCT05195281 | Pancreatic Cancer Evolution Upon Treatment | recruiting | N/A | 80 | IRCCS San RaffaeleOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06071507 | Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy(GOOSE) | recruiting | — | 250 | IRCCS San RaffaeleOTHER | 4 | Jan 15, 2026 | clinicaltrials |
| NCT06356467 | Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs(FARINET) | recruiting | — | 450 | IRCCS San RaffaeleOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06753903 | Role of Photon Counting CT in Detecting Liver Metastatis From Colorectal Cancer(PCDCRC-D34H) | recruiting | — | 100 | IRCCS San RaffaeleOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06640413 | A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors(TheraTri) | recruiting | Phase 1 | 56 | Philogen S.p.A.INDUSTRY | 1 | Jan 14, 2026 | clinicaltrials |
| NCT04689347 | 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. | recruiting | Phase 1 / Phase 2 | 27 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT06163430 | A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)(CARDINAL) | recruiting | Phase 1 / Phase 2 | 180 | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 9 | Jan 12, 2026 | clinicaltrials |
| NCT07305090 | Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut(GUT-PREDICTION) | recruiting | — | 90 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06265727 | A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors | recruiting | Phase 1 / Phase 2 | 348 | Corbus Pharmaceuticals Inc.INDUSTRY | 7 | Jan 8, 2026 | clinicaltrials |
| NCT07325864 | Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site | recruiting | — | 25 | European Institute of OncologyOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06300125 | Percutaneous Cryoablation of Low-risk Early Breast Cancer(PRECICE) | recruiting | — | 234 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06328465 | fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases(fREEDOM) | recruiting | N/A | 145 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07049133 | Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer(Tox-DXd) | recruiting | — | 84 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07080944 | Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC(SYMPHONY) | recruiting | N/A | 75 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07319416 | DCEUS to Assess Treatment Response to PRRT in GEP-NET(DCEUS-PRRT) | recruiting | N/A | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06690840 | Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients(AZALEA) | recruiting | Phase 2 | 45 | European Institute of OncologyOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT02829437 | Observational Study on Endometrial Stromal Tumors(EST) | recruiting | — | 100 | Italian Sarcoma GroupNETWORK | 1 | Jan 2, 2026 | clinicaltrials |
| NCT02986516 | Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease(SACRO) | recruiting | N/A | 100 | Italian Sarcoma GroupNETWORK | 10 | Jan 2, 2026 | clinicaltrials |
| NCT04749446 | Study on Clinical Features and Outcomes of Breast Sarcoma(Breast-Sarc) | recruiting | — | 300 | Italian Sarcoma GroupNETWORK | 1 | Jan 2, 2026 | clinicaltrials |
| NCT04845893 | Observational Study on Skeletal Ewing's Sarcoma(EWOss) | recruiting | — | 100 | Italian Sarcoma GroupNETWORK | 1 | Jan 2, 2026 | clinicaltrials |
| NCT07313943 | PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE(HL PAX5- 2025) | recruiting | — | 60 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 2 | Jan 2, 2026 | clinicaltrials |
| NCT07313982 | LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION(LLC/LEF1 2024) | recruiting | — | 350 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT05962541 | Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)(CUT-less) | recruiting | Phase 4 | 327 | University of Roma La SapienzaOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05816850 | Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial(FIL_FOLL-BIO) | recruiting | — | 654 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06008691 | A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice(FIL_MAB) | recruiting | — | 1,500 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06588205 | Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma(FIL_MIMYC) | recruiting | — | 200 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07304856 | Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex | recruiting | — | 80 | University of MilanOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07274163 | Ambispective Registry of Patients Affected by Lung Cancer | recruiting | — | 1,500 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06690775 | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | recruiting | Phase 2 | 230 | TORL Biotherapeutics, LLCINDUSTRY | 12 | Dec 23, 2025 | clinicaltrials |
| NCT07299812 | BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART(BRAVE-HEART) | recruiting | — | 400 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05817227 | Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.(Selebrec) | recruiting | — | 300 | National Cancer Institute, NaplesOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06270602 | The ONCOCAMP Study | recruiting | — | 15,000 | National Cancer Institute, NaplesOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06017557 | Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer(PREDAtOOR) | recruiting | N/A | 151 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06511648 | Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations(SOGUG-NEOWIN) | recruiting | Phase 2 | 90 | Spanish Oncology Genito-Urinary GroupOTHER | 4 | Dec 19, 2025 | clinicaltrials |
| NCT06800586 | Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects(RECAP) | recruiting | — | 300 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06994208 | Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.(MELA_2025) | recruiting | — | 25 | Ente Ospedaliero Ospedali GallieraOTHER | 1 | Dec 19, 2025 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials